Susan Mahony
CIK 1463321 · SVP & Pres., Lilly Oncology · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$63.16M
Companies
5
Total Filings
62
Lifetime Open-Market Net
-$13.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AXSM | Director | 829 | $255.17 | $211.5K | -$145.0K | 7 | 2026-06-10 |
| ASMB | Director | — | $22.96 | — | $0 | 10 | 2026-06-05 |
| ZYME | Director | — | $22.88 | — | $0 | 6 | 2026-01-12 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Director | 0 | $116.30 | $0 | $0 | 7 | 2023-10-06 |
| LLY | SVP & Pres., Lilly Oncology | 55,559 | $1133.00 | $62.95M | -$13.25M | 32 | 2019-02-01 |
Recent Filings · Page 5 of 7
62 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-03 | LLY | Mixed | +5,214 | -$366.2K | EDGAR |
| 2016-01-28 | LLY | Grant (A) | +20,242 | $1.66M | EDGAR |
| 2015-07-29 | LLY | Sell (S) | −25,000 | -$2.12M | EDGAR |
| 2015-02-12 | LLY | Mixed | +971 | -$60.9K | EDGAR |
| 2015-02-03 | LLY | Mixed | +6,670 | -$426.3K | EDGAR |
| 2015-01-30 | LLY | Grant (A) | +28,461 | $2.02M | EDGAR |
| 2014-08-15 | LLY | Mixed | +732 | -$1 | EDGAR |
| 2014-07-30 | LLY | Mixed | +175 | -$130.7K | EDGAR |
| 2014-07-28 | LLY | Sell (S) | −30,000 | -$1.92M | EDGAR |
| 2014-02-04 | LLY | Mixed | +7,480 | -$357.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.